Finance

Lists
IMMX:NASDAQ
Immix Biopharma Inc
$13.66
+3.80%
(+0.50) 1D
$13.60
-0.44% (-0.060)
After hours
Closed: Aug 21, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IMMX...
Open
$13.36
High
$13.76
Low
$13.12
Mkt. cap
977.23M
Avg. vol.
1.61M
Volume
1.51M
52-wk high
$13.76
52-wk low
$1.94
EPS
-$0.87
Beta
0.11
Shares outstanding
71.54M
No. of employees
21
Open
$13.36
High
$13.76
Low
$13.12
Mkt. cap
977.23M
Avg. vol.
1.61M
Volume
1.51M
52-wk high
$13.76
52-wk low
$1.94
EPS
-$0.87
Beta
0.11
Shares outstanding
71.54M
No. of employees
21
News stories
From web sources and news partners
About Immix Biopharma Inc
CEO-
Employees21
Founded2012
HeadquartersLos Angeles, California, United States
SectorBiotechnology
Websiteimmixbio.com
Analyst ratings
Based on 6 analysts giving stock ratings to IMMX in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for IMMX in the last 3 months.
Highest
Current $13.66
$25.00 (+83.02%)
Average
$19.80 (+44.95%)
Lowest
$15.00 (+9.81%)
Analyst
Recommendation
Action
Price target
Projected
Date
Tazeen Ahmad
Bank of America Securities
Buy
Maintained
-
-
08/14/2026
Graig Suvannavejh
Mizuho Securities
Buy
Reiterated
$15.00
+9.8%
08/12/2026
Judah Frommer
Morgan Stanley
Buy
Reiterated
$19.00
+39.1%
08/11/2026
Gil Blum
Needham
Buy
Maintained
$21.00
+53.7%
08/10/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
$25.00
+83%
08/10/2026
Patrick Dolezal
LifeSci Capital
Buy
Initiated
$19.00
+39.1%
06/17/2026
Reni Benjamin
Citizens JMP
Buy
Initiated
$23.00
+68.4%
03/09/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4.58M
5.73M
5.98M
5.33M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.08M
5.17M
4.82M
7.12M
Operating expense
7.66M
10.89M
10.80M
12.46M
Total operating expenses
7.66M
10.89M
10.80M
12.46M
Operating income
-7.66M
-10.89M
-10.80M
-12.46M
Other non operating income
-
-
-
-
EBT including unusual items
-7.58M
-10.68M
-10.09M
-11.54M
EBT excluding unusual items
-7.58M
-10.68M
-10.09M
-11.54M
Income tax expense
7.72K
11.27K
-
14.32K
Effective tax rate
-0.10%
-0.11%
-
-0.12%
Other operating expenses
-
-
-
-
Net income
-7.59M
-10.69M
-10.09M
-11.56M
Net profit margin
-
-
-
-
Earnings per share
-0.24
-0.28
-0.18
-0.18
Interest and investment income
84.54K
216.71K
717.17K
913.66K
Interest expense
-
-
-
-
Net interest expenses
84.54K
216.71K
717.17K
913.66K
Depreciation and amortization charges
-
-
-
-
EBITDA
-7.57M
-10.84M
-10.71M
-12.37M
Gain or loss from assets sale
-
-
34.15K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps